tiprankstipranks
Advertisement
Advertisement

Exchange Seeks Clarification from Indo US Bio-Tech on Q2 FY2025 Results

Story Highlights
  • The exchange has asked Indo US Bio-Tech to clarify its September 2025 quarterly results.
  • Investors await the company’s pending response on its regulatory financial disclosures.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Exchange Seeks Clarification from Indo US Bio-Tech on Q2 FY2025 Results

Meet Samuel – Your Personal Investing Prophet

Indo US Bio-Tech Ltd. ( (IN:INDOUS) ) has issued an announcement.

The stock exchange has requested Indo US Bio-Tech Ltd. to provide clarifications regarding its financial results for the quarter ended 30 September 2025 under Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements. The company’s response is still pending, leaving investors and other stakeholders awaiting further information on its quarterly financial disclosures and compliance status.

More about Indo US Bio-Tech Ltd.

Average Trading Volume: 5,145

Technical Sentiment Signal: Sell

Current Market Cap: 2.42B INR

Find detailed analytics on INDOUS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1